超血症的管理:来自科威特的专家共识 - 修改后的德尔菲方法
Ali AlSahow1, Bassam Bulbanat2, Bassam Alhelal3
1Nephrology division, Jahra Hospital, Al Jahra, Kuwait.
International journal of nephrology and renovascular disease
|October 10, 2024
概括
这一共识为心力衰竭,慢性病和血液透析患者的高胆固醇血症管理提供了专家指导. 它解决了当前高卡血症治疗指南中的不一致问题.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心脏衰竭 (HF) 患者中患有高胆固醇血高血是普遍存在的,这些患者接受氨酸- ангиотензин- 阿尔多素抑制剂 (RAASi),慢性脏病 (CKD) 和血液透析.
- 它使患者管理复杂化,并限制了基本RAASi治疗的使用.
- 新的结合剂,如环酸 (SZC) 显示出有效性,但不一致的指导方针阻碍了它们的采用.
研究的目的:
- 为急性环境,高血压,慢性脏病和血液透析中高血管理制定共识声明.
- 为解决阿拉伯湾地区缺乏标准化治疗方案的问题.
- 为科威特的医疗保健从业人员提供实际指导.
主要方法:
- 一个经过修改的三步德尔菲方法,涉及12名科威特专家.
- 两轮投票,并进行间接的虚拟会议,讨论非一致的声明.
- 关于高血症管理的44个共识声明的制定和投票.
主要成果:
- 该共识包括44个声明,涵盖跨不同临床环境的高卡利米亚管理.
- 在第一轮投票中,36项声明获得了一致的批准.
- 四个陈述被删除,四个在第二轮修订后被批准.
结论:
- 缺乏标准化的定义,治疗门和一致的指导方针来管理高血症.
- 这种共识旨在建立一个统一的方法,在科威特治疗高血症.
- 该声明强调了未来需要改进高血症护理的需求.
相关概念视频
01:20Acute Kidney Injury V: Interprofessional Care
2
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
2
01:22Acute Kidney Injury VI: Nursing Management
2
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
2
01:28Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
01:18Chronic Kidney Disease IV: Nursing Management
2
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
2
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
469
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
469
01:25Dysrhythmias VI: Management of Dysrhythmias
3
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
3